1/29
07:41 am
mdgl
Madrigal Pharmaceuticals (NASDAQ:MDGL) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
Low
Report
Madrigal Pharmaceuticals (NASDAQ:MDGL) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
1/28
09:41 am
mdgl
Rating for MDGL
Low
Report
Rating for MDGL
1/28
09:41 am
mdgl
Rating for MDGL
Low
Report
Rating for MDGL
1/27
06:00 pm
mdgl
Madrigal Pharmaceuticals (NASDAQ:MDGL) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
Low
Report
Madrigal Pharmaceuticals (NASDAQ:MDGL) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
1/27
04:26 pm
mdgl
Madrigal Pharmaceuticals initiated with an Overweight at Barclays
Low
Report
Madrigal Pharmaceuticals initiated with an Overweight at Barclays
1/27
04:26 pm
mdgl
Madrigal Pharmaceuticals initiated with an Overweight at Barclays
Low
Report
Madrigal Pharmaceuticals initiated with an Overweight at Barclays
1/20
07:01 am
mdgl
Madrigal Pharmaceuticals (NASDAQ:MDGL) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Madrigal Pharmaceuticals (NASDAQ:MDGL) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
1/6
08:06 am
mdgl
Madrigal Pharmaceuticals (NASDAQ:MDGL) was downgraded by analysts at Wolfe Research from an "outperform" rating to a "peer perform" rating.
Medium
Report
Madrigal Pharmaceuticals (NASDAQ:MDGL) was downgraded by analysts at Wolfe Research from an "outperform" rating to a "peer perform" rating.
1/6
08:06 am
mdgl
Madrigal Pharmaceuticals (NASDAQ:MDGL) was downgraded by analysts at Wolfe Research from an "outperform" rating to a "peer perform" rating.
Medium
Report
Madrigal Pharmaceuticals (NASDAQ:MDGL) was downgraded by analysts at Wolfe Research from an "outperform" rating to a "peer perform" rating.
1/6
07:44 am
mdgl
Madrigal Pharmaceuticals downgraded to Peer Perform from Outperform at Wolfe Research
Medium
Report
Madrigal Pharmaceuticals downgraded to Peer Perform from Outperform at Wolfe Research
1/6
07:44 am
mdgl
Madrigal Pharmaceuticals downgraded to Peer Perform from Outperform at Wolfe Research
Medium
Report
Madrigal Pharmaceuticals downgraded to Peer Perform from Outperform at Wolfe Research
12/11
09:10 am
mdgl
Madrigal Pharmaceuticals (NASDAQ:MDGL) had its "buy" rating reaffirmed by analysts at B. Riley.
Medium
Report
Madrigal Pharmaceuticals (NASDAQ:MDGL) had its "buy" rating reaffirmed by analysts at B. Riley.
12/11
09:10 am
mdgl
Madrigal Pharmaceuticals (NASDAQ:MDGL) had its "buy" rating reaffirmed by analysts at B. Riley.
Medium
Report
Madrigal Pharmaceuticals (NASDAQ:MDGL) had its "buy" rating reaffirmed by analysts at B. Riley.
12/9
08:11 am
mdgl
Madrigal Pharmaceuticals (NASDAQ:MDGL) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Low
Report
Madrigal Pharmaceuticals (NASDAQ:MDGL) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
11/20
06:07 am
mdgl
Rating for MDGL
Medium
Report
Rating for MDGL
11/20
06:07 am
mdgl
Rating for MDGL
Medium
Report
Rating for MDGL
11/5
08:18 am
mdgl
Rating for MDGL
Medium
Report
Rating for MDGL
11/5
07:19 am
mdgl
Madrigal Pharmaceuticals (NASDAQ:MDGL) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Madrigal Pharmaceuticals (NASDAQ:MDGL) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
11/4
06:02 pm
mdgl
Madrigal Pharmaceuticals (NASDAQ:MDGL) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating.
Medium
Report
Madrigal Pharmaceuticals (NASDAQ:MDGL) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating.
11/4
04:14 pm
mdgl
Madrigal Pharmaceuticals upgraded to Overweight from Neutral at Cantor Fitzgerald
Medium
Report
Madrigal Pharmaceuticals upgraded to Overweight from Neutral at Cantor Fitzgerald